NAVITOR PHARMACEUTICALS INC has a total of 45 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ROBERTS LAB INC, PTC THERAPEUTICS MP INC and BYK NEDERLAND BV.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Colombia | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Singapore | 2 | |
#12 | Hong Kong | 1 | |
#13 | Mexico | 1 | |
#14 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Saiah Eddine | 38 |
#2 | O'Neill David John | 28 |
#3 | Kang Seong Woo Anthony | 15 |
#4 | Narayan Sridhar | 14 |
#5 | Fetalvero Kristina Michelle | 13 |
#6 | Sengupta Shomit | 13 |
#7 | Brearley Andrew | 7 |
#8 | Bentley Jonathan | 7 |
#9 | Vlasuk George | 7 |
#10 | Eddine Saiah | 3 |
Publication | Filing date | Title |
---|---|---|
US2020131114A1 | Polymorphic compounds and uses thereof | |
AU2019286524A1 | Rapamycin analogs and uses thereof | |
CA3061611A1 | Modulators of sestrin-gator2 interaction and uses thereof | |
WO2018191146A1 | Heteroaryl rheb inhibitors and uses thereof | |
WO2018089499A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | |
WO2018089433A1 | PHENYL mTORC INHIBITORS AND USES THEREOF | |
US2019389843A1 | PYRROLE mTORC INHIBITORS AND USES THEREOF | |
WO2018089493A1 | PYRROLE mTORC INHIBITORS AND USES THEREOF | |
EP3364958A1 | Modulators of sestrin-gator2 interaction and uses thereof | |
WO2017044720A1 | Rapamycin analogs and uses thereof |